脑肿瘤切除开颅术中脑室进入的并发症
回顾性分析2010年1月至2012年11月在亨利·福特医院因脑肿瘤切除行开颅术的183例病例,比较术中进入脑室与否的并发症。进入脑室组任何并发症发生率显著更高(46% vs 21%),包括外引流管置入、脑积水、脑室内出血、感染及帽状腱膜下积液;胶质母细胞瘤亚组中位生存期329天 vs 522天(HR 1.13,95%CI 0.65-1.96;p=0.67)。
要点
- 进入脑室组任何并发症发生率46%,未进入组21%。
- 进入脑室组外引流管置入23% vs 1%(p<0.001),脑积水6% vs 0%(p=0.03)。
- 进入脑室组脑室内出血14% vs 0%(p<0.001),感染15% vs 5%(p=0.04),帽状腱膜下积液20% vs 4%(p<0.001)。
核心结论
- 脑肿瘤切除术中进入脑室者并发症多于未进入脑室者。
- 作者认为应积极寻找脑室旁肿瘤切除的更好管理策略以改善切除程度和生存。
研究设计与样本
- 回顾性分析2010年1月至2012年11月在亨利·福特医院因脑肿瘤切除行开颅术的183例病例。
- 关注术中进入脑室系统、术后使用脑室外引流管(EVD)、硬膜下血肿、脑积水和症状性脑室内出血(IVH)。
主要发现
- 进入脑室组任何并发症发生率46% vs 未进入组21%。
- 进入脑室组EVD置入23% vs 1%(p<0.001),脑积水6% vs 0%(p=0.03)。
- 进入脑室组IVH 14% vs 0%(p<0.001),感染15% vs 5%(p=0.04),帽状腱膜下积液20% vs 4%(p<0.001)。
- 脑室腹腔(VP)分流仅见于进入脑室病例(11% vs 0%,p=0.001),其中4例中3例为大进入(定义为大于针孔[<3 mm]进入)。
- 胶质母细胞瘤亚组中位生存期进入脑室组329天 vs 未进入组522天(HR 1.13,95%CI 0.65-1.96;p=0.67)。
关键数值与推荐
- 进入脑室组任何并发症46% vs 未进入组21%。
- 进入脑室组EVD置入23% vs 1%(p<0.001)。
- 进入脑室组脑积水6% vs 0%(p=0.03),IVH 14% vs 0%(p<0.001)。
- 进入脑室组感染15% vs 5%(p=0.04),帽状腱膜下积液20% vs 4%(p<0.001)。
- VP分流进入脑室组11% vs 未进入组0%(p=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Recent studies have demonstrated that periventricular tumor location is associated with poorer survival and that tumor location near the ventricle limits the extent of resection. This finding may relate to the perception that ventricular entry leads to further complications and thus surgeons may choose to perform less aggressive resection in these areas. However, there is little support for this view in the literature. This study seeks to determine whether ventricular entry is associated with more complications during craniotomy for brain tumor resection. METHODS A retrospective analysis of patients who underwent craniotomy for tumor resection at Henry Ford Hospital between January 2010 and November 2012 was conducted. A total of 183 cases were reviewed with attention to operative entry into the ventricular system, postoperative use of an external ventricular drain (EVD), subdural hematoma, hydrocephalus, and symptomatic intraventricular hemorrhage (IVH). RESULTS Patients in whom the ventricles were entered had significantly higher rates of any complication (46% vs 21%). Complications included development of subdural hygroma, subdural hematoma, intraventricular hemorrhage, subgaleal collection, wound infection, urinary tract infection/deep venous thrombosis, hydrocephalus, and ventriculoperitoneal (VP) shunt placement. Specifically, these patients had significantly higher rates of EVD placement (23% vs 1%, p < 0.001), hydrocephalus (6% vs 0%, p = 0.03), IVH (14% vs 0%, p < 0.001), infection (15% vs 5%, p = 0.04), and subgaleal collection (20% vs 4%, p < 0.001). It was also observed that VP shunt placement was only seen in cases of ventricular entry (11% vs 0%, p = 0.001) with 3 of 4 of these patients having a large ventricular entry (defined here as entry greater than a pinhole [< 3 mm] entry). Furthermore, in a subset of glioblastoma patients with and without ventricular entry, Kaplan-Meier estimates for survival demonstrated a median survival time of 329 days for ventricular entry compared with 522 days for patients with no ventricular entry (HR 1.13, 95% CI 0.65-1.96; p = 0.67). CONCLUSIONS There are more complications associated with ventricular entry during brain tumor resection than in nonviolated ventricular systems. Better strategies for management of periventricular tumor resection should be actively sought to improve resection and survival for these patients.
引用
- John JK, Robin AM, Pabaney AH, et al. Complications of ventricular entry during craniotomy for brain tumor resection. J Neurosurg. 2016. PMID: 27813467. doi:10.3171/2016.7.JNS16340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。